Natriuretic peptide system: An overview of studies using genetically engineered animal models

FEBS Journal

Volumn 278, Issue 11, 2011, Pages 1830-1841

  Kishimoto, Ichiro ^a   Tokudome, Takeshi ^a   Nakao, Kazuwa ^b   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

bone; cardiac hypertrophy; guanylyl cyclase; hypertension; natriuretic peptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR ALPHA; ATRIAL NATRIURETIC FACTOR RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C; RGS4 PROTEIN;

ACUTE HEART FAILURE; ARTERIAL PRESSURE; BLOOD FLOW VELOCITY; BLOOD PRESSURE REGULATION; BLOOD VOLUME; BONE GROWTH; CARDIOVASCULAR FUNCTION; DRUG MECHANISM; EXPERIMENTAL ANIMAL; GENE INACTIVATION; GENE OVEREXPRESSION; GENE TARGETING; HEART INFARCTION; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HUMAN; LEG ISCHEMIA; LIGAND BINDING; MOLECULAR PATHOLOGY; MUSCULOSKELETAL FUNCTION; NONHUMAN; OSSIFICATION; PARACRINE SIGNALING; PEPTIDE ANALYSIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN ENGINEERING; REVIEW; SIGNAL TRANSDUCTION; TARGET ORGAN; TRANSGENIC ANIMAL;

ANIMALS; GENETIC ENGINEERING; MODELS, ANIMAL; NATRIURETIC PEPTIDES;

ANIMALIA; MAMMALIA;

EID: 79956223447     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08116.x     Document Type: Review

References (67)

1. de Bold AJ, Borenstein HB, Veress AT, &, Sonnenberg H, (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28, 89-94. (Pubitemid 11184926)
2. Flynn TG, de Bold ML, &, de Bold AJ, (1983) The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 117, 859-865. (Pubitemid 14185048)
3. Thibault G, Garcia R, Seidah NG, Lazure C, Cantin M, Chrétien M, &, Genest J, (1983) Purification of three rat atrial natriuretic factors and their amino acid composition. FEBS Lett 164, 286-290. (Pubitemid 14222736)
4. Kangawa K, &, Matsuo H, (1984) Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide (alpha-hANP). Biochem Biophys Res Commun 118, 131-139. (Pubitemid 14191955)
5. Misono KS, Fukumi H, Grammer RT, &, Inagami T, (1984) Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity. Biochem Biophys Res Commun 119, 524-529. (Pubitemid 14133963)
6. Currie MG, Geller DM, Cole BR, Siegel NR, Fok KF, Adams SP, Eubanks SR, Galluppi GR, &, Needleman P, (1984) Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science 223, 67-69.
7. Kangawa K, Tawaragi Y, Oikawa S, Mizuno A, Sakuragawa Y, Nakazato H, Fukuda A, Minamino N, &, Matsuo H, (1984) Identification of rat atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor. Nature 312, 152-155. (Pubitemid 14000077)
8. Sudoh T, Kangawa K, Minamino N, &, Matsuo H, (1988) A new natriuretic peptide in porcine brain. Nature 332, 78-81. (Pubitemid 18083551)
9. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, et al. (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87, 1402-1412.
10. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, &, Nakao K, (1995) Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J Clin Invest 96, 1280-1287.
11. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, &, Imura H, (1990) Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323, 757-758. (Pubitemid 20288962)
12. Sudoh T, Minamino N, Kangawa K, &, Matsuo H, (1990) C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168, 863-870. (Pubitemid 20164622)
13. Suga S, Itoh H, Komatsu Y, Ishida H, Igaki T, Yamashita J, Doi K, Chun TH, Yoshimasa T, Tanaka I, et al. (1998) Regulation of endothelial production of C-type natriuretic peptide by interaction between endothelial cells and macrophages. Endocrinology 139, 1920-1926. (Pubitemid 28513853)
14. Naruko T, Ueda M, van der Wal AC, van der Loos CM, Itoh H, Nakao K, &, Becker AE, (1996) C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation 94, 3103-3108. (Pubitemid 26427474)
15. Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, &, Schenk DB, (1988) Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J Biol Chem 263, 9395-9401.
16. Anand-Srivastava MB, Sehl PD, &, Lowe DG, (1996) Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein. J Biol Chem 271, 19324-19329. (Pubitemid 26271602)
17. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin HM, Goeddel DV, &, Schulz S, (1989) A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338, 78-83. (Pubitemid 19076788)
18. Chang MS, Lowe DG, Lewis M, Hellmiss R, Chen E, &, Goeddel DV, (1989) Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341, 68-72. (Pubitemid 19220660)
19. Schulz S, Singh S, Bellet RA, Singh G, Tubb DJ, Chin H, &, Garbers DL, (1989) The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58, 1155-1162. (Pubitemid 19238191)
20. Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, Matsuo H, &, Goeddel DV, (1991) Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252, 120-123. (Pubitemid 21916951)
21. Suga S, Nakao K, Kishimoto I, Hosoda K, Mukoyama M, Arai H, Shirakami G, Ogawa Y, Komatsu Y, Nakagawa O, et al. (1992) Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130, 229-239.
22. Steinhelper ME, Cochrane KL, &, Field LJ, (1990) Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16, 301-307. (Pubitemid 20313292)
23. Ogawa Y, Itoh H, Tamura N, Suga S, Yoshimasa T, Uehira M, Matsuda S, Shiono S, Nishimoto H, &, Nakao K, (1994) Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest 93, 1911-1921. (Pubitemid 24143068)
24. John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, &, Smithies O, (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267, 679-681.
25. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, Friesen J, Garbers DL, &, Beuve A, (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378, 65-68.
26. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, Reddick RL, Pandey KN, Milgram SL, Smithies O, &, Maeda N, (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94, 14730-14735. (Pubitemid 28041442)
27. Oliver PM, John SW, Purdy KE, Kim R, Maeda N, Goy MF, &, Smithies O, (1998) Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc Natl Acad Sci USA 95, 2547-2551. (Pubitemid 28145979)
28. Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, &, Smithies O, (1999) The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 96, 7403-7408. (Pubitemid 29299674)
29. Yoshimoto T, Naruse M, Naruse K, Shionoya K, Tanaka M, Tanabe A, Hagiwara H, Hirose S, Muraki T, &, Demura H, (1996) Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats. Endocrinology 137, 1102-1107. (Pubitemid 26074137)
30. Kishimoto I, Yoshimasa T, Suga S, Ogawa Y, Komatsu Y, Nakagawa O, Itoh H, &, Nakao K, (1994) Natriuretic peptide clearance receptor is transcriptionally down-regulated by beta 2-adrenergic stimulation in vascular smooth muscle cells. J Biol Chem 269, 28300-28308. (Pubitemid 24354571)
31. Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, Kasahara M, Hashimoto R, Katsuura G, Mukoyama M, et al. (2000) Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97, 4239-4244. (Pubitemid 30226117)
32. Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA, Yanagisawa M, &, Kuhn M, (2005) Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest 115, 1666-1674. (Pubitemid 40814676)
33. Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, Zetsche B, Hammer RE, Herz J, &, Kuhn M, (2002) Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 99, 7142-7147. (Pubitemid 34526269)
34. Kishimoto I, Dubois SK, &, Garbers DL, (1996) The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci USA 93, 6215-6219. (Pubitemid 26190830)
35. Shi SJ, Vellaichamy E, Chin SY, Smithies O, Navar LG, &, Pandey KN, (2003) Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol Renal Physiol 285, F694-F702. (Pubitemid 37140253)
36. Potter LR, Abbey-Hosch S, &, Dickey DM, (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27, 47-72. (Pubitemid 43228238)
37. Curry FR, (2005) Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport, and plasma volume. J Clin Invest 115, 1458-1461.
38. Nakao K, Itoh H, Saito Y, Mukoyama M, &, Ogawa Y, (1996) The natriuretic peptide family. Curr Opin Nephrol Hypertens 5, 4-11. (Pubitemid 26088556)
39. Kishimoto I, Rossi K, &, Garbers DL, (2001) A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc Natl Acad Sci USA 98, 2703-2706. (Pubitemid 32209546)
40. Kuhn M, Holtwick R, Baba HA, Perriard JC, Schmitz W, &, Ehler E, (2002) Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice. Heart 87, 368-374. (Pubitemid 34270952)
41. Knowles JW, Esposito G, Mao L, Hagaman JR, Fox JE, Smithies O, Rockman HA, &, Maeda N, (2001) Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest 107, 975-984. (Pubitemid 32328002)
42. Kishimoto I, Tokudome T, Horio T, Garbers DL, Nakao K, &, Kangawa K, (2009) Natriuretic peptide signaling via guanylyl cyclase (GC)-A: an endogenous protective mechanism of the heart. Curr Cardiol Rev 5, 45-51.
43. Holtwick R, van Eickels M, Skryabin BV, Baba HA, Bubikat A, Begrow F, Schneider MD, Garbers DL, &, Kuhn M, (2003) Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 111, 1399-1407. (Pubitemid 36554711)
44. Molkentin JD, (2003) A friend within the heart: natriuretic peptide receptor signaling. J Clin Invest 111, 1275-1277. (Pubitemid 36554695)
45. Tokudome T, Horio T, Kishimoto I, Soeki T, Mori K, Kawano Y, Kohno M, Garbers DL, Nakao K, &, Kangawa K, (2005) Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. Circulation 111, 3095-3104. (Pubitemid 40847787)
46. Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, Frampton CM, Richards AM, &, Cameron VA, (2007) Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol 38, 245-257. (Pubitemid 46351607)
47. Tang KM, Wang GR, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y, et al. (2003) Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9, 1506-1512. (Pubitemid 38004778)
48. Tokudome T, Kishimoto I, Horio T, Arai Y, Schwenke DO, Hino J, Okano I, Kawano Y, Kohno M, Miyazato M, et al. (2008) Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart. Circulation 117, 2329-2339. (Pubitemid 351653552)
49. Tang KM, Wang GR, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y, et al. (2009) Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice. J Clin Invest 119, 408-420.
50. Klaiber M, Kruse M, Völker K, Schröter J, Feil R, Freichel M, Gerling A, Feil S, Dietrich A, Londoño JE, et al. (2010) Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2. Basic Res Cardiol 105, 583-595.
51. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, &, Nakao K, (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88, 82-91. (Pubitemid 23195436)
52. Nakanishi M, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Kawakami R, Nakagawa Y, Tanimoto K, Yasuno S, et al. (2005) Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice. Hypertension 46, 441-447. (Pubitemid 41099182)
53. Yamahara K, Itoh H, Chun TH, Ogawa Y, Yamashita J, Sawada N, Fukunaga Y, Sone M, Yurugi-Kobayashi T, Miyashita K, et al. (2003) Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration. Proc Natl Acad Sci USA 100, 3404-3409. (Pubitemid 36356596)
54. Park K, Itoh H, Yamahara K, Sone M, Miyashita K, Oyamada N, Sawada N, Taura D, Inuzuka M, Sonoyama T, et al. (2008) Therapeutic potential of atrial natriuretic peptide administration on peripheral arterial diseases. Endocrinology 149, 483-491. (Pubitemid 351159359)
55. Tokudome T, Kishimoto I, Yamahara K, Osaki T, Minamino N, Horio T, Sawai K, Kawano Y, Miyazato M, Sata M, et al. (2009) Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides. Arterioscler Thromb Vasc Biol 29, 1516-1521.
56. Kuhn M, Völker K, Schwarz K, Carbajo-Lozoya J, Flögel U, Jacoby C, Stypmann J, van Eickels M, Gambaryan S, Hartmann M, et al. (2009) The natriuretic peptide/guanylyl cyclase-a system functions as a stress-responsive regulator of angiogenesis in mice. J Clin Invest 119, 2019-2030.
57. Suda M, Ogawa Y, Tanaka K, Tamura N, Yasoda A, Takigawa T, Uehira M, Nishimoto H, Itoh H, Saito Y, et al. (1998) Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci USA 95, 2337-2342. (Pubitemid 28145942)
58. Chusho H, Ogawa Y, Tamura N, Suda M, Yasoda A, Miyazawa T, Kishimoto I, Komatsu Y, Itoh H, Tanaka K, et al. (2000) Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptor-mediated pathways. Endocrinology 141, 3807-3813.
59. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, et al. (2001) Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 98, 4016-4021. (Pubitemid 32249890)
60. Tamura N, Doolittle LK, Hammer RE, Shelton JM, Richardson JA, &, Garbers DL, (2004) Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc Natl Acad Sci USA 101, 17300-17305. (Pubitemid 39627814)
61. Das S, Au E, Krazit ST, &, Pandey KN, (2010) Targeted disruption of guanylyl cyclase-A/natriuretic peptide receptor-A gene provokes renal fibrosis and remodeling in null mutant mice: role of proinflammatory cytokines. Endocrinology 151, 5841-5850.
62. Kishimoto I, Tokudome T, Horio T, Soeki T, Chusho H, Nakao K, &, Kangawa K, (2008) C-type natriuretic peptide is a Schwann cell-derived factor for development and function of sensory neurones. J Neuroendocrinol 20, 1213-1223.
63. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, et al. (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10, 80-86. (Pubitemid 38524702)
64. Kake T, Kitamura H, Adachi Y, Yoshioka T, Watanabe T, Matsushita H, Fujii T, Kondo E, Tachibe T, Kawase Y, et al. (2009) Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. Am J Physiol Endocrinol Metab 297, E1339-E1348.
65. Wang Y, de Waard MC, Sterner-Kock A, Stepan H, Schultheiss HP, Duncker DJ, &, Walther T, (2007) Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Fail 9, 548-557. (Pubitemid 46702821)
66. Schmidt H, Stonkute A, Jüttner R, Koesling D, Friebe A, &, Rathjen FG, (2009) C-type natriuretic peptide (CNP) is a bifurcation factor for sensory neurons. Proc Natl Acad Sci USA 106, 16847-16852.
67. Langenickel TH, Buttgereit J, Pagel-Langenickel I, Lindner M, Monti J, Beuerlein K, Al-Saadi N, Plehm R, Popova E, Tank J, et al. (2006) Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc Natl Acad Sci USA 103, 4735-4740.